Global Nuclear Medicine Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 237804
  • calendar_today Published On: Dec, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Nuclear Medicine Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nuclear Medicine Therapy size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Nuclear Medicine Therapy market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Nuclear Medicine Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Radium-223

Lutetium-177

Iodine-131

Other

Market segment by Application, can be divided into

Thyroid

Bone Metastasis

Lymphoma

Other

Market segment by players, this report covers

Novartis

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Dongcheng

Lantheus

Acrotech Biopharma.

Progenics Pharmaceuticals

International Isotopes

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Nuclear Medicine Therapy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Nuclear Medicine Therapy, with revenue, gross margin and global market share of Nuclear Medicine Therapy from 2019 to 2021.

Chapter 3, the Nuclear Medicine Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Nuclear Medicine Therapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Nuclear Medicine Therapy research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Nuclear Medicine Therapy

1.2 Classification of Nuclear Medicine Therapy by Type

1.2.1 Overview: Global Nuclear Medicine Therapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Nuclear Medicine Therapy Revenue Market Share by Type in 2020

1.2.3 Radium-223

1.2.4 Lutetium-177

1.2.5 Iodine-131

1.2.6 Other

1.3 Global Nuclear Medicine Therapy Market by Application

1.3.1 Overview: Global Nuclear Medicine Therapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Global Nuclear Medicine Therapy Market Size & Forecast

1.5 Global Nuclear Medicine Therapy Market Size and Forecast by Region

1.5.1 Global Nuclear Medicine Therapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Nuclear Medicine Therapy Market Size by Region, (2016-2021)

1.5.3 North America Nuclear Medicine Therapy Market Size and Prospect (2016-2026)

1.5.4 Europe Nuclear Medicine Therapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Nuclear Medicine Therapy Market Size and Prospect (2016-2026)

1.5.6 South America Nuclear Medicine Therapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Nuclear Medicine Therapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Nuclear Medicine Therapy Market Drivers

1.6.2 Nuclear Medicine Therapy Market Restraints

1.6.3 Nuclear Medicine Therapy Trends Analysis

2 Company Profiles

2.1 Novartis

2.1.1 Novartis Details

2.1.2 Novartis Major Business

2.1.3 Novartis Nuclear Medicine Therapy Product and Solutions

2.1.4 Novartis Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Novartis Recent Developments and Future Plans

2.2 Bayer

2.2.1 Bayer Details

2.2.2 Bayer Major Business

2.2.3 Bayer Nuclear Medicine Therapy Product and Solutions

2.2.4 Bayer Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Bayer Recent Developments and Future Plans

2.3 China Isotope & Radiation

2.3.1 China Isotope & Radiation Details

2.3.2 China Isotope & Radiation Major Business

2.3.3 China Isotope & Radiation Nuclear Medicine Therapy Product and Solutions

2.3.4 China Isotope & Radiation Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 China Isotope & Radiation Recent Developments and Future Plans

2.4 Q BioMed

2.4.1 Q BioMed Details

2.4.2 Q BioMed Major Business

2.4.3 Q BioMed Nuclear Medicine Therapy Product and Solutions

2.4.4 Q BioMed Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Q BioMed Recent Developments and Future Plans

2.5 Curium Pharmaceuticals

2.5.1 Curium Pharmaceuticals Details

2.5.2 Curium Pharmaceuticals Major Business

2.5.3 Curium Pharmaceuticals Nuclear Medicine Therapy Product and Solutions

2.5.4 Curium Pharmaceuticals Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Curium Pharmaceuticals Recent Developments and Future Plans

2.6 Jubilant DraxImage

2.6.1 Jubilant DraxImage Details

2.6.2 Jubilant DraxImage Major Business

2.6.3 Jubilant DraxImage Nuclear Medicine Therapy Product and Solutions

2.6.4 Jubilant DraxImage Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Jubilant DraxImage Recent Developments and Future Plans

2.7 Dongcheng

2.7.1 Dongcheng Details

2.7.2 Dongcheng Major Business

2.7.3 Dongcheng Nuclear Medicine Therapy Product and Solutions

2.7.4 Dongcheng Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Dongcheng Recent Developments and Future Plans

2.8 Lantheus

2.8.1 Lantheus Details

2.8.2 Lantheus Major Business

2.8.3 Lantheus Nuclear Medicine Therapy Product and Solutions

2.8.4 Lantheus Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Lantheus Recent Developments and Future Plans

2.9 Acrotech Biopharma.

2.9.1 Acrotech Biopharma. Details

2.9.2 Acrotech Biopharma. Major Business

2.9.3 Acrotech Biopharma. Nuclear Medicine Therapy Product and Solutions

2.9.4 Acrotech Biopharma. Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Acrotech Biopharma. Recent Developments and Future Plans

2.10 Progenics Pharmaceuticals

2.10.1 Progenics Pharmaceuticals Details

2.10.2 Progenics Pharmaceuticals Major Business

2.10.3 Progenics Pharmaceuticals Nuclear Medicine Therapy Product and Solutions

2.10.4 Progenics Pharmaceuticals Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Progenics Pharmaceuticals Recent Developments and Future Plans

2.11 International Isotopes

2.11.1 International Isotopes Details

2.11.2 International Isotopes Major Business

2.11.3 International Isotopes Nuclear Medicine Therapy Product and Solutions

2.11.4 International Isotopes Nuclear Medicine Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 International Isotopes Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Nuclear Medicine Therapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Nuclear Medicine Therapy Players Market Share

3.2.2 Top 10 Nuclear Medicine Therapy Players Market Share

3.2.3 Market Competition Trend

3.3 Nuclear Medicine Therapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Nuclear Medicine Therapy Revenue and Market Share by Type (2016-2021)

4.2 Global Nuclear Medicine Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Nuclear Medicine Therapy Revenue Market Share by Application (2016-2021)

5.2 Nuclear Medicine Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Nuclear Medicine Therapy Revenue by Type (2016-2026)

6.2 North America Nuclear Medicine Therapy Revenue by Application (2016-2026)

6.3 North America Nuclear Medicine Therapy Market Size by Country

6.3.1 North America Nuclear Medicine Therapy Revenue by Country (2016-2026)

6.3.2 United States Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

6.3.3 Canada Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Nuclear Medicine Therapy Revenue by Type (2016-2026)

7.2 Europe Nuclear Medicine Therapy Revenue by Application (2016-2026)

7.3 Europe Nuclear Medicine Therapy Market Size by Country

7.3.1 Europe Nuclear Medicine Therapy Revenue by Country (2016-2026)

7.3.2 Germany Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

7.3.3 France Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

7.3.5 Russia Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

7.3.6 Italy Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Nuclear Medicine Therapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Nuclear Medicine Therapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Nuclear Medicine Therapy Market Size by Region

8.3.1 Asia-Pacific Nuclear Medicine Therapy Revenue by Region (2016-2026)

8.3.2 China Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

8.3.3 Japan Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

8.3.5 India Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

8.3.7 Australia Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Nuclear Medicine Therapy Revenue by Type (2016-2026)

9.2 South America Nuclear Medicine Therapy Revenue by Application (2016-2026)

9.3 South America Nuclear Medicine Therapy Market Size by Country

9.3.1 South America Nuclear Medicine Therapy Revenue by Country (2016-2026)

9.3.2 Brazil Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Nuclear Medicine Therapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Nuclear Medicine Therapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Nuclear Medicine Therapy Market Size by Country

10.3.1 Middle East & Africa Nuclear Medicine Therapy Revenue by Country (2016-2026)

10.3.2 Turkey Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

10.3.4 UAE Nuclear Medicine Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Nuclear Medicine Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Nuclear Medicine Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Nuclear Medicine Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Nuclear Medicine Therapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Nuclear Medicine Therapy Revenue Market Share by Region (2021-2026)

Table 6. Novartis Corporate Information, Head Office, and Major Competitors

Table 7. Novartis Major Business

Table 8. Novartis Nuclear Medicine Therapy Product and Solutions

Table 9. Novartis Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Bayer Corporate Information, Head Office, and Major Competitors

Table 11. Bayer Major Business

Table 12. Bayer Nuclear Medicine Therapy Product and Solutions

Table 13. Bayer Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. China Isotope & Radiation Corporate Information, Head Office, and Major Competitors

Table 15. China Isotope & Radiation Major Business

Table 16. China Isotope & Radiation Nuclear Medicine Therapy Product and Solutions

Table 17. China Isotope & Radiation Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Q BioMed Corporate Information, Head Office, and Major Competitors

Table 19. Q BioMed Major Business

Table 20. Q BioMed Nuclear Medicine Therapy Product and Solutions

Table 21. Q BioMed Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Curium Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 23. Curium Pharmaceuticals Major Business

Table 24. Curium Pharmaceuticals Nuclear Medicine Therapy Product and Solutions

Table 25. Curium Pharmaceuticals Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Jubilant DraxImage Corporate Information, Head Office, and Major Competitors

Table 27. Jubilant DraxImage Major Business

Table 28. Jubilant DraxImage Nuclear Medicine Therapy Product and Solutions

Table 29. Jubilant DraxImage Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Dongcheng Corporate Information, Head Office, and Major Competitors

Table 31. Dongcheng Major Business

Table 32. Dongcheng Nuclear Medicine Therapy Product and Solutions

Table 33. Dongcheng Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Lantheus Corporate Information, Head Office, and Major Competitors

Table 35. Lantheus Major Business

Table 36. Lantheus Nuclear Medicine Therapy Product and Solutions

Table 37. Lantheus Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Acrotech Biopharma. Corporate Information, Head Office, and Major Competitors

Table 39. Acrotech Biopharma. Major Business

Table 40. Acrotech Biopharma. Nuclear Medicine Therapy Product and Solutions

Table 41. Acrotech Biopharma. Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Progenics Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 43. Progenics Pharmaceuticals Major Business

Table 44. Progenics Pharmaceuticals Nuclear Medicine Therapy Product and Solutions

Table 45. Progenics Pharmaceuticals Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. International Isotopes Corporate Information, Head Office, and Major Competitors

Table 47. International Isotopes Major Business

Table 48. International Isotopes Nuclear Medicine Therapy Product and Solutions

Table 49. International Isotopes Nuclear Medicine Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Global Nuclear Medicine Therapy Revenue (USD Million) by Players (2019-2021)

Table 51. Global Nuclear Medicine Therapy Revenue Share by Players (2019-2021)

Table 52. Breakdown of Nuclear Medicine Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Nuclear Medicine Therapy Players Head Office, Products and Services Provided

Table 54. Nuclear Medicine Therapy Mergers & Acquisitions in the Past Five Years

Table 55. Nuclear Medicine Therapy New Entrants and Expansion Plans

Table 56. Global Nuclear Medicine Therapy Revenue (USD Million) by Type (2016-2021)

Table 57. Global Nuclear Medicine Therapy Revenue Share by Type (2016-2021)

Table 58. Global Nuclear Medicine Therapy Revenue Forecast by Type (2021-2026)

Table 59. Global Nuclear Medicine Therapy Revenue by Application (2016-2021)

Table 60. Global Nuclear Medicine Therapy Revenue Forecast by Application (2021-2026)

Table 61. North America Nuclear Medicine Therapy Revenue by Type (2016-2021) & (USD Million)

Table 62. North America Nuclear Medicine Therapy Revenue by Type (2021-2026) & (USD Million)

Table 63. North America Nuclear Medicine Therapy Revenue by Application (2016-2021) & (USD Million)

Table 64. North America Nuclear Medicine Therapy Revenue by Application (2021-2026) & (USD Million)

Table 65. North America Nuclear Medicine Therapy Revenue by Country (2016-2021) & (USD Million)

Table 66. North America Nuclear Medicine Therapy Revenue by Country (2021-2026) & (USD Million)

Table 67. Europe Nuclear Medicine Therapy Revenue by Type (2016-2021) & (USD Million)

Table 68. Europe Nuclear Medicine Therapy Revenue by Type (2021-2026) & (USD Million)

Table 69. Europe Nuclear Medicine Therapy Revenue by Application (2016-2021) & (USD Million)

Table 70. Europe Nuclear Medicine Therapy Revenue by Application (2021-2026) & (USD Million)

Table 71. Europe Nuclear Medicine Therapy Revenue by Country (2016-2021) & (USD Million)

Table 72. Europe Nuclear Medicine Therapy Revenue by Country (2021-2026) & (USD Million)

Table 73. Asia-Pacific Nuclear Medicine Therapy Revenue by Type (2016-2021) & (USD Million)

Table 74. Asia-Pacific Nuclear Medicine Therapy Revenue by Type (2021-2026) & (USD Million)

Table 75. Asia-Pacific Nuclear Medicine Therapy Revenue by Application (2016-2021) & (USD Million)

Table 76. Asia-Pacific Nuclear Medicine Therapy Revenue by Application (2021-2026) & (USD Million)

Table 77. Asia-Pacific Nuclear Medicine Therapy Revenue by Region (2016-2021) & (USD Million)

Table 78. Asia-Pacific Nuclear Medicine Therapy Revenue by Region (2021-2026) & (USD Million)

Table 79. South America Nuclear Medicine Therapy Revenue by Type (2016-2021) & (USD Million)

Table 80. South America Nuclear Medicine Therapy Revenue by Type (2021-2026) & (USD Million)

Table 81. South America Nuclear Medicine Therapy Revenue by Application (2016-2021) & (USD Million)

Table 82. South America Nuclear Medicine Therapy Revenue by Application (2021-2026) & (USD Million)

Table 83. South America Nuclear Medicine Therapy Revenue by Country (2016-2021) & (USD Million)

Table 84. South America Nuclear Medicine Therapy Revenue by Country (2021-2026) & (USD Million)

Table 85. Middle East & Africa Nuclear Medicine Therapy Revenue by Type (2016-2021) & (USD Million)

Table 86. Middle East & Africa Nuclear Medicine Therapy Revenue by Type (2021-2026) & (USD Million)

Table 87. Middle East & Africa Nuclear Medicine Therapy Revenue by Application (2016-2021) & (USD Million)

Table 88. Middle East & Africa Nuclear Medicine Therapy Revenue by Application (2021-2026) & (USD Million)

Table 89. Middle East & Africa Nuclear Medicine Therapy Revenue by Country (2016-2021) & (USD Million)

Table 90. Middle East & Africa Nuclear Medicine Therapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Nuclear Medicine Therapy Picture

Figure 2. Global Nuclear Medicine Therapy Revenue Market Share by Type in 2020

Figure 3. Radium-223

Figure 4. Lutetium-177

Figure 5. Iodine-131

Figure 6. Other

Figure 7. Nuclear Medicine Therapy Revenue Market Share by Application in 2020

Figure 8. Thyroid Picture

Figure 9. Bone Metastasis Picture

Figure 10. Lymphoma Picture

Figure 11. Other Picture

Figure 12. Global Nuclear Medicine Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Nuclear Medicine Therapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Nuclear Medicine Therapy Revenue Market Share by Region (2016-2026)

Figure 15. Global Nuclear Medicine Therapy Revenue Market Share by Region in 2020

Figure 16. North America Nuclear Medicine Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Nuclear Medicine Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Nuclear Medicine Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Nuclear Medicine Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Nuclear Medicine Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Nuclear Medicine Therapy Market Drivers

Figure 22. Nuclear Medicine Therapy Market Restraints

Figure 23. Nuclear Medicine Therapy Market Trends

Figure 24. Novartis Recent Developments and Future Plans

Figure 25. Bayer Recent Developments and Future Plans

Figure 26. China Isotope & Radiation Recent Developments and Future Plans

Figure 27. Q BioMed Recent Developments and Future Plans

Figure 28. Curium Pharmaceuticals Recent Developments and Future Plans

Figure 29. Jubilant DraxImage Recent Developments and Future Plans

Figure 30. Dongcheng Recent Developments and Future Plans

Figure 31. Lantheus Recent Developments and Future Plans

Figure 32. Acrotech Biopharma. Recent Developments and Future Plans

Figure 33. Progenics Pharmaceuticals Recent Developments and Future Plans

Figure 34. International Isotopes Recent Developments and Future Plans

Figure 35. Global Nuclear Medicine Therapy Revenue Share by Players in 2020

Figure 36. Nuclear Medicine Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 37. Global Top 3 Players Nuclear Medicine Therapy Revenue Market Share in 2020

Figure 38. Global Top 10 Players Nuclear Medicine Therapy Revenue Market Share in 2020

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 40. Global Nuclear Medicine Therapy Revenue Share by Type in 2020

Figure 41. Global Nuclear Medicine Therapy Market Share Forecast by Type (2021-2026)

Figure 42. Global Nuclear Medicine Therapy Revenue Share by Application in 2020

Figure 43. Global Nuclear Medicine Therapy Market Share Forecast by Application (2021-2026)

Figure 44. North America Nuclear Medicine Therapy Sales Market Share by Type (2016-2026)

Figure 45. North America Nuclear Medicine Therapy Sales Market Share by Application (2016-2026)

Figure 46. North America Nuclear Medicine Therapy Revenue Market Share by Country (2016-2026)

Figure 47. United States Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Canada Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Mexico Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Europe Nuclear Medicine Therapy Sales Market Share by Type (2016-2026)

Figure 51. Europe Nuclear Medicine Therapy Sales Market Share by Application (2016-2026)

Figure 52. Europe Nuclear Medicine Therapy Revenue Market Share by Country (2016-2026)

Figure 53. Germany Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Nuclear Medicine Therapy Sales Market Share by Type (2016-2026)

Figure 59. Asia-Pacific Nuclear Medicine Therapy Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Nuclear Medicine Therapy Revenue Market Share by Region (2016-2026)

Figure 61. China Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Japan Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South Korea Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. India Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Southeast Asia Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Australia Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South America Nuclear Medicine Therapy Sales Market Share by Type (2016-2026)

Figure 68. South America Nuclear Medicine Therapy Sales Market Share by Application (2016-2026)

Figure 69. South America Nuclear Medicine Therapy Revenue Market Share by Country (2016-2026)

Figure 70. Brazil Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Argentina Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Middle East and Africa Nuclear Medicine Therapy Sales Market Share by Type (2016-2026)

Figure 73. Middle East and Africa Nuclear Medicine Therapy Sales Market Share by Application (2016-2026)

Figure 74. Middle East and Africa Nuclear Medicine Therapy Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. UAE Nuclear Medicine Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz